Value of Transvaginal Two-Dimensional Contrast-Enhanced Ultrasonography in Diagnosing Atypical Ovarian Corpus Luteum Hematoma

<table class="fixed-width table-group" id="tab5"><tr><td><table class="table"><colgroup><col style="width:8.15em"/><col style="width:5.23em"/><col style="width:3.09em"/><col style="width:4.20em"/><col style="width:3.04em"/></colgroup><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left" rowspan="2">Group</td><td class="align_center" rowspan="2">Cases (N)</td><td class="align_center" colspan="3">RI</td></tr><tr class="thead"><td class="align_center">≤0.4</td><td class="align_center">0.4–0.5</td><td class="align_center">≥0.5</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">AT-OCLH</td><td class="align_center">18</td><td class="align_center">6</td><td class="align_center">9</td><td class="align_center">3</td></tr><tr><td class="align_left">Malignant tumor</td><td class="align_center">6</td><td class="align_center">2</td><td class="align_center">3</td><td class="align_center">1</td></tr><tr><td class="align_left">U value</td><td class="align_center"> </td><td class="align_center"> </td><td class="align_center">54.000</td><td class="align_center"> </td></tr><tr><td class="align_left"><i>P</i></td><td class="align_center"> </td><td class="align_center"> </td><td class="align_center">1.000</td><td class="align_center"> </td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Comparing RI values in AT-OCLH and malignant tumors group.</div>

BioMed Research International

tab5

Table 5

Table 5: Value of Transvaginal Two-Dimensional Contrast-Enhanced Ultrasonography in Diagnosing Atypical Ovarian Corpus Luteum Hematoma 